We believe we can do an impact together

The Bookind project aims to innovate a companion diagnostic product that predicts use of specific therapeutics in Epilepsy. The project is led by the University of Malta through Professor Mauro Pessia. It is funded under the FUSION program administered by the Malta Council for Science and Technology (MCST).

JOIN US and SUBSCRIBE below for more information on other innovative products and applications.

Product Development and Projects

CoV-plex

To develop a molecular test that measures COVID-19 (SARS-CoV-2) immune response for vaccine surveillance.

iMPACT

Innovative molecular profiling assays to classify tumours. We developed multiplex assays for academic research and lab based testing programs.

M3 PROFILER

To synergise the advantages of microfluidics, and multiplex bead based assays, to measure biomarkers in blood-derived exosomes.